Wellcare is ready to become your Medicare partner!
The Annual Enrollment Period for your Medicare patients runs from October 15 to December 7. Your patients have a choice in their Medicare health insurance, and we hope that they will use this Annual Enrollment Period to get acquainted with Wellcare. If they ask you about their coverage options, let them know you accept Wellcare.
As our partner, you can count on our complete support as you continue to focus on providing compassionate and expert care to your patients. Our most helpful provider resources include:
- 2024 Wellcare Provider Manual (PDF)
- 2025 Wellcare Provider Manual (PDF)
- 2026 Wellcare Provider Manual (PDF)
- 2025 Alternative Covered Drugs (PDF)
- 2026 Alternative Covered Drugs (PDF)
- Provider Orientation Toolkit
- Provider Companion Guides
- 2026 Appeals/Reconsiderations (Medical) and Grievances Guide (PDF)
- 2026 Claims, Disputes & Recovery/CCU Guide (PDF)
- Appeals Guide 2025 (PDF)
- Claim Submission Guide 2025 (PDF)
- Pharmacy Guide (PDF)
- Pharmacy Guide 2026 (PDF)
- Prior Authorization Guide 2026 (PDF)
- Provider QRG (PDF)
- Medicare Quick Reference Guide 2026 (PDF)
- Appointment Availability Standards (PDF)
- Step Therapy Part B Provider updated (PDF)
Further provider resources, including dedicated Provider Relations and Contracting contacts, can be found on the Nebraska Total Care’s website at www.nebraskatotalcare.com/providers.html. Wellcare is the Medicare product offered through Nebraska Total Care.
Questions?
- Non-Duals/C-SNP 1-800-977-7522 (TTY: 711)
- Duals/D-SNP 1-844-796-6811 (TTY: 711)
Special Supplemental Benefits for the Chronically Ill (SSBCI) can be offered to Medicare Advantage (MA) members who have one or more complex chronic conditions, are at high risk for hospitalization or adverse health outcomes and require intensive care coordination. SSBCI aims to improve overall health outcomes for the chronically ill population by addressing social needs beyond traditional medical care such as food, housing, transportation, and gaps in care. The program is designed to support individuals by offering additional services beyond standard Medicare coverage.
Members must qualify for SSBCI benefits
Members must meet all three criteria to qualify:
- The member must require intensive care management.
- The member must have a history of frequent outpatient services or specialty care and/or, evidence of poor disease control or medication adherence and/or, social or behavioral factors impacting health outcomes.
- The member must be at high risk for unplanned hospitalization.
- The member must have a history of frequent hospitalizations or ED visits related to the chronic condition.
- The member must have a documented and active diagnosis for a qualifying chronic condition.
- The chronic condition must be life threatening or significantly limit the overall health or function of the member.
How to Determine Eligibility
Auto Eligibility Process: We utilize internal and claims data in our internal algorithm to identify members that meet the three criteria. This automatic process refreshes weekly, and links member data across time and health plans, enabling a comprehensive view of historical claims. This process includes all members enrolled in an SSBCI-eligible plan.
Manual Eligibility Process: We may not have claims data or medical records for new members early in the year. These members can go through the manual process to have a provider attest to their eligibility.
To begin the SSBCI manual eligibility process, members must schedule an in-person office visit or contact their healthcare provider to request the attestation be completed. If an office visit is required to complete the attestation, the provider will evaluate the member’s health status during the visit and determine if they meet SSBCI criteria.
Provider Instructions for SSBCI Attestation
Providers should follow these steps to complete the attestation:
- Visit ssbci.rrd.com.
- Review the eligibility criteria outlined on the site (see criteria above) and evaluate the member accordingly.
- Submit an attestation through the website confirming the member meets SSBCI eligibility requirements.
- Submit a claim from the office visit that includes the appropriate diagnosis codes indicating the member has one or more What Happens Next?qualifying chronic conditions listed on ssbci.rrd.com.
What Happens Next?
Once the attestation is received:
- The member will receive an approval or denial letter within 10 business days.
- If approved, the letter will include details about the specific SSBCI benefits available and instructions on how to access them.
- Provider Medicine Request Checklist (PDF)
- Prior Authorization Information (PDF)
- Wellcare Health Plans Utilization Review Matrix 2021 (PDF)
- Provider Outreach and Clinical Engagement Strategy for Wellcare (PDF)
FAQ's-
- Evolent FAQ's For Wellcare Providers (PDF)
- Evolent FAQ's Wellcare Prior Authorization Physical Medicine (PDF)
Cardiac-
- Cardiac Checklist (PDF)
- Cardiac Imaging Frequently Asked Questions (PDF)
- Cardiac Solution Program Tip Sheet MPI vs. SE (PDF)
Quick Reference Guides-
For Medicare information, please visit our Medicare Prior Authorization website.
- Distinct Procedural Service: Modifier 59 (PDF) Effective 1/17/2023
- Robotic Surgery (PDF) Effective 1/1/2022
- CC.PP.206 Skilled Nursing Facility Leveling (PDF) Effective Date 01/01/2024
- MC.CP.MP.101 Donor Lymphocyte Infusion (PDF) Effective Date 01/01/2024
- MC.CP.MP.106 Endometrial Ablation (PDF) Effective Date 01/01/2024
- MC.CP.MP.108 Allogeneic Hematopoietic Cell Transplants for Sickle Cell Anemia and ß-Thalassemia (PDF) Effective Date 01/01/2024
- MC.CP.MP.160 Implantable Wireless Pulmonary Artery Pressure Monitoring (PDF) Effective Date 01/01/2024
- MC.CP.MP.170 Peripheral Nerve Blocks (PDF) Effective Date 01/01/2024
- MC.CP.MP.182 Short Inpatient Hospital Stay (PDF) Effective Date 01/01/2024
- MC.CP.MP.22 Stereotactic Radiation Therapy (PDF) Effective Date 01/01/2024
- MC.CP.MP.246 Pediatric Kidney Transplan (PDF) Effective Date 01/01/2024
- MC.CP.MP.57 Lung Transplantation (PDF) Effective Date 01/01/2024
- MC.CP.MP.69 Intensity Modulated Radiation Therapy (IMRT) (PDF) Effective Date 01/01/2024
- Concert Genetics Genetic Testing: Aortopathies and Connective Tissue Disorders (PDF) Effective Date 01/01/2024
- Concert Genetic Testing: Cardiac Disorders (PDF) Effective Date 01/01/2024
- Concert Genetic Testing: Dermatologic Conditions (PDF) Effective Date 01/01/2024
- Concert Genetic Testing: Epilepsy, Neurodegenerative, and Neuromuscular Conditions (PDF) Effective Date 01/01/2024
- Concert Genetic Testing: Exome and Genome Sequencing for the Diagnosis of Genetic Disorders (PDF) Effective Date 01/01/2024
- Concert Genetic Testing: Eye Disorders (PDF) Effective Date 01/01/2024
- Concert Genetic Testing: Gastroenterologic Disorders (non-cancerous) (PDF) Effective Date 01/01/2024
- Concert Genetic Testing: General Approach to Genetic Testing (PDF) Effective Date 01/01/2024
- Concert Genetic Testing: Hearing Loss (PDF) Effective Date 01/01/2024
- Concert Genetic Testing: Hematologic Conditions (non-cancerous) (PDF) Effective Date 01/01/2024
- Concert Genetic Testing: Hereditary Cancer Susceptibility (PDF) Effective Date 01/01/2024
- Concert Genetic Testing: Immune, Autoimmune, and Rheumatoid Disorders (PDF) Effective Date 01/01/2024
- Concert Genetic Testing: Kidney Disorders (PDF) Effective Date 01/01/2024
- Concert Genetic Testing: Lung Disorders (PDF) Effective Date 01/01/2024
- Concert Genetic Testing: Metabolic, Endocrine, and Mitochondrial Disorders (PDF) Effective Date 01/01/2024
- Concert Genetic Testing: Multisystem Inherited Disorders, Intellectual Disability, and Developmental Delay (PDF) Effective Date 01/01/2024
- Concert Genetic Testing: Non-invasive Prenatal Screening (NIPS) (PDF) Effective Date 01/01/2024
- Concert Genetics Oncology: Algorithmic Testing (PDF) Effective Date 01/01/2024
- Concert Genetics Oncology: Cancer Screening (PDF) Effective Date 01/01/2024
- Concert Genetics Oncology: Circulating Tumor DNA and Circulating Tumor Cells (PDF) Effective Date 01/01/2024
- Concert Genetics Oncology: Cytogenetic Testing (PDF) Effective Date 01/01/2024
- Concert Genetics Oncology: Molecular Analysis of Solid Tumors and Hematologic Malignancies (PDF) Effective Date 01/01/2024
- Concert Genetic Testing: Pharmacogenetics (PDF) Effective Date 01/01/2024
- Concert Genetic Testing: Preimplantation Genetic Testing (PDF) Effective Date 01/01/2024
- Concert Genetic Testing: Prenatal and Preconception Carrier Screening (PDF) Effective Date 01/01/2024
- Concert Genetic Testing: Prenatal Diagnosis (via Amniocentesis, CVS, or PUBS) and Pregnancy Loss (PDF) Effective Date 01/01/2024
- Concert Genetic Testing: Skeletal Dysplasia and Rare Bone Disorders (PDF) Effective Date 01/01/2024
- CG.CP.MP.01 Infectious Disease: Respiratory Lab Testing (PDF) Effective Date: 07/01/2024
- CG.CP.MP.02 Infectious Disease: Multi-System Lab Testing (PDF) Effective Date: 07/01/2024
- CG.CP.MP.03 Infectious Disease: Dermatologic Testing (PDF) Effective Date: 07/01/2024
- CG.CP.MP.04 Infectious Disease: Gastroenterologic Lab Testing (PDF) Effective Date: 07/01/2024
- CG.CP.MP.05 Infectious Disease: Primary Care & Preventative Lab Screening (PDF) Effective Date: 07/01/2024
- CG.CP.MP.06 Infectious Disease: Vector-Borne and Tropical Disease Lab Testing (PDF) Effective Date: 07/01/2024
- CG.CP.MP.07 Infectious Disease: Genitourinary Lab Testing (PDF) Effective Date: 07/01/2024
- Concert Genetic Lab Testing Clinical Criteria Support (PDF)
- MC.CP.MP.249 Omisirge 6/30/2024
- MC.CP.MP.250 Lantidra 7/31/2024
- MC.CP.MP.31 Cosmetic and Reconstruction Procedures 8/31/2024
- MC.CP.MP.166 Sacroiliac Joint Interventions for Pain Management 8/31/2024
- CP.MP.248 Facility-based Sleep Studies for Obstructive Sleep Apnea Effective Date: 01/01/2025
- CP.MP.96 Ambulatory EEG (PDF)
- CP.MP.106 Endometrial Ablation (PDF)
- CP.MP.113 Holter Monitors (PDF)
- CP.MP.149 PROM Testing
- CP.MP.54 Hospice Services (PDF)
- CC.PP.500 3 Day Payment Window (PDF)
- CC.PP.070 340B Drug Payment Reduction (PDF)
- OC.UM.CP.0043 External Ocular Photography (PDF)
- CC.PP.065 Multiple Diagnostic Cardiovascular Procedure Payment Reduction (MDCR) (PDF)
- CC.PP.069 Multiple Procedure Reduction: Ophthalmology (PDF)
- CC.PP.061 Non-Obstetrical and OB Pelvic and Transvaginal Ultrasounds (PDF)
- CC.PP.035 Sleep Studies Place of Service (PDF)
- CC.PP.056 Urine Speciment Validity Testing (PDF)
- CC.PP.502 Wheelchairs Accessories (PDF)
- CC.PP.501 30 Day Readmission (PDF)
- CC.PP.066 Leveling of Care: Evaluation and Management Overcoding (PDF) effective date: 09/01/2025
- CC.PP.053 Non-Emergent ER Services (fka Leveling of ER Services) (PDF)
- CC.PP.054 Physician's Consultation Services (PDF)
- CC.PP.057 Problem-Oriented Visits with Preventative Visits (PDF)
- CC.PP.052 Problem-Oriented Visits with Surgical Procedures
- CC.PP.020 Distinct Procedural Modifiers: XE, XS, XP, & XU (PDF)
- CC.Pl.04 Clean Claim Reviews (PDF)
- CC.Pl.06 Cost to Charge Adjustments on Clean Claim Reviews (PDF)
- CC.Pl.10 Unbundling Adjustments on Clean Claim Reviews (PDF)
- CC.PP.014 District Procedure Mod 59
- CC.PP.031 CMS Correct Coding Initative Unbundling Edits (PDF)
- CG.CC.PP.01 Concert Laboratory Payment Policy (PDF) Effective Date: 07/01/2024
- CG.PP.551 Genetic and Molecular Testing (PDF) Effective Date: 07/01/2024
- CC.PP.206 Skilled Nursing Facility Leveling Effective Date: 08/31/2024
- CC.PP.076 Leveling of Care: Emergency Department (Effective 11/01/2025
- Level of Care: Evaluation and Management Overcoding for Professional Services Effective Date: 11/01/2025